Biowatch

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion

Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan. By combining the foundational research and technical...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the Ministry of Food and Drug Safety for...
Skin Aging Is More Than Collagen Loss: GC Green Cross Wellbeing Unveils Next-Gen ECM Booster in the Philippines

Skin Aging Is More Than Collagen Loss: GC Green Cross Wellbeing Unveils Next-Gen ECM Booster in the Philippines

When skin begins to sag and lose its glow, many people attribute the change solely to declining collagen.
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon

During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate

Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...
Cho Jae-ho Assumes Leadership of Chuncheon Sacred Heart Hospital

Cho Jae-ho Assumes Leadership of Chuncheon Sacred Heart Hospital

Cho Jae-ho, a professor of orthopedic surgery, officially assumed office as the 23rd director of Hallym University...
SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

SK Plasma Launches High-Dose Revolpag 75 mg to Simplify Thrombocytopenia Regimens and Cut Costs

SK Plasma announced on Sept. 1 that it has begun distributing Revolpag Tablets 75 mg in South Korea, expanding its...
Shin Hyung-ik Appointed Director of National Traffic Injury Rehabilitation Hospital

Shin Hyung-ik Appointed Director of National Traffic Injury Rehabilitation Hospital

For patients who suffer severe injuries in traffic crashes or fall accidents, medical care does not end when emergency...
JW Pharmaceutical Expands 'Frenz' Brand Beyond Eye Drops with Launch of 'Eye Crunch' Candy

JW Pharmaceutical Expands 'Frenz' Brand Beyond Eye Drops with Launch of 'Eye Crunch' Candy

JW Pharmaceutical is rolling out the first product extension under its flagship eye-care brand, Frenz, marking the...
Lee Jae-joon Takes Helm at Hallym University Medical Center, Pledges Unified Synergy Across Five Hospitals

Lee Jae-joon Takes Helm at Hallym University Medical Center, Pledges Unified Synergy Across Five Hospitals

Hallym University Medical Center announced that Lee Jae-joon, former president of Hallym University Chuncheon Sacred...